Prague, Czechia

Olena Butenko

This inventor holds 1 USPTO granted patent. Top assignee: Pharmafox Therapeutics Ag. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olena Butenko. Retrieved from https://idiyas.com/inventor/olena-butenko

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Olena Butenko: Innovator in Muscle Performance Improvement

Introduction

Olena Butenko is a prominent inventor based in Prague, Czech Republic. She has made significant contributions to the field of neuromuscular treatments through her innovative research and development. Her work focuses on improving muscle performance and addressing neuromuscular diseases.

Latest Patents

Olena Butenko holds a patent for "Muscle performance improvement compounds comprising C-terminus agrin fragment and an ACTR2B inhibitor." This patent describes a compound that includes at least two components: a first component being the nLG3 or (h)nLG3 domain from the C-terminus of mouse or human agrin, and at least one second component selected from proteins or an antagonistic antibody that inhibits ActR2B-induced signaling activity in the presence of myostatin. These compounds are designed to be effective treatments for neuromuscular diseases and related issues. She has 1 patent to her name.

Career Highlights

Olena is currently associated with Pharmafox Therapeutics AG, where she continues her research and development efforts. Her work has garnered attention for its potential impact on treating neuromuscular disorders.

Collaborations

Olena collaborates with notable colleagues, including Jan Willem Vrijbloed and Marina Maria Boido, who contribute to her research initiatives.

Conclusion

Olena Butenko is a dedicated inventor whose work in muscle performance improvement compounds holds promise for advancing treatments for neuromuscular diseases. Her innovative approach and collaboration with esteemed colleagues highlight her commitment to making a difference in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…